Protein Mfn2 may increase the currently short therapeutic window in stroke
A new study published in the prestigious publication The EMBO Journal shows that the mitochondrial protein Mfn2 may be a future therapeutic target for neuronal death reduction in the late phases of an ischemic stroke. The ...
Sep 24, 2014
0
0